These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 15284756

  • 1. Expression and regulation of luteinizing hormone/human chorionic gonadotropin receptors in ovarian cancer and its correlation to human chorionic gonadotropin-doxorubicin sensitivity.
    Gebauer G, Mueller N, Fehm T, Berkholz A, Beck EP, Jaeger W, Licht P.
    Am J Obstet Gynecol; 2004 Jun; 190(6):1621-8; discussion 1628. PubMed ID: 15284756
    [Abstract] [Full Text] [Related]

  • 2. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR, Gründker C, Bongertz T, Schlott T, Nagy A, Schally AV, Emons G.
    Am J Obstet Gynecol; 2004 Oct; 191(4):1164-72. PubMed ID: 15507937
    [Abstract] [Full Text] [Related]

  • 3. Expression of variant luteinizing hormone/chorionic gonadotropin receptors and degradation of chorionic gonadotropin in human chorionic villous macrophages.
    Sonoda N, Katabuchi H, Tashiro H, Ohba T, Nishimura R, Minegishi T, Okamura H.
    Placenta; 2005 Apr; 26(4):298-307. PubMed ID: 15823616
    [Abstract] [Full Text] [Related]

  • 4. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S, Schlotawa L, Günthert AR, Emons G, Gründker C.
    Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic effect of conjugates of doxorubicin and human chorionic gonadotropin (hCG) in breast cancer cells.
    Gebauer G, Fehm T, Beck EP, Berkholz A, Licht P, Jäger W.
    Breast Cancer Res Treat; 2003 Jan; 77(2):125-31. PubMed ID: 12602911
    [Abstract] [Full Text] [Related]

  • 6. Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR, Gründker C, Bongertz T, Nagy A, Schally AV, Emons G.
    Breast Cancer Res Treat; 2004 Oct; 87(3):255-64. PubMed ID: 15528968
    [Abstract] [Full Text] [Related]

  • 7. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.
    Choi JH, Choi KC, Auersperg N, Leung PC.
    Endocr Relat Cancer; 2006 Jun; 13(2):641-51. PubMed ID: 16728589
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alternately spliced luteinizing hormone/human chorionic gonadotropin receptor mRNA in human breast epithelial cells.
    Jiang X, Russo IH, Russo J.
    Int J Oncol; 2002 Apr; 20(4):735-8. PubMed ID: 11894118
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of human chorionic gonadotropin (hCG)--doxorubicin conjugates against ovarian cancer cells.
    Beck EP, Vincenti D, Licht P, Berkholz A, Jäger W, Lang N, Merkle E.
    Anticancer Res; 2000 Apr; 20(5A):3001-6. PubMed ID: 11062714
    [Abstract] [Full Text] [Related]

  • 11. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells.
    Syed V, Ulinski G, Mok SC, Yiu GK, Ho SM.
    Cancer Res; 2001 Sep 15; 61(18):6768-76. PubMed ID: 11559549
    [Abstract] [Full Text] [Related]

  • 12. Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells.
    Warrenfeltz SW, Lott SA, Palmer TM, Gray JC, Puett D.
    Mol Cancer Res; 2008 Nov 15; 6(11):1775-85. PubMed ID: 19010824
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeting breast and prostate cancers through their hormone receptors.
    Leuschner C, Hansel W.
    Biol Reprod; 2005 Nov 15; 73(5):860-5. PubMed ID: 16033998
    [Abstract] [Full Text] [Related]

  • 15. Regulation of the angiopoietin-2 gene by hCG in ovarian cancer cell line OVCAR-3.
    Pietrowski D, Wiehle P, Sator M, Just A, Keck C.
    Horm Metab Res; 2010 May 15; 42(5):328-33. PubMed ID: 20213583
    [Abstract] [Full Text] [Related]

  • 16. Targeted doxorubicin-containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers.
    Bajo AM, Schally AV, Halmos G, Nagy A.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3742-8. PubMed ID: 14506166
    [Abstract] [Full Text] [Related]

  • 17. Functional luteinizing hormone/chorionic gonadotropin receptors in human adrenal cortical H295R cells.
    Rao ChV, Zhou XL, Lei ZM.
    Biol Reprod; 2004 Aug 01; 71(2):579-87. PubMed ID: 15084485
    [Abstract] [Full Text] [Related]

  • 18. Bombesin and epidermal growth factor potentiate the effect of cytotoxic LH-RH analog AN-152 in vitro.
    Krebs LJ, Wang X, Nagy A, Schally AV, Prasad PN, Liebow C.
    Int J Oncol; 2002 Dec 01; 21(6):1325-9. PubMed ID: 12429984
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors.
    Kidd M, Schally AV, Pfragner R, Malfertheiner MV, Modlin IM.
    Cancer; 2008 Mar 15; 112(6):1404-14. PubMed ID: 18224665
    [Abstract] [Full Text] [Related]

  • 20. Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207.
    Engel JB, Keller G, Schally AV, Nagy A, Chism DD, Halmos G.
    Fertil Steril; 2005 Apr 15; 83 Suppl 1():1125-33. PubMed ID: 15831285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.